Drug manufacturing problems bad for business but good for jobs

Problems plaguing drug manufacturers are bad for business but apparently good for the job market.

According to a report in Pharmalot, hiring for quality control and regulatory areas are a genuine "bright spot" in the market. Citing first quarter data from executive search firm ZRG Partners, it says that sector of the industry saw a 15% hiring increase, in a global pharmaceutical and medical device market that only experienced a 3.7% jump.

The report says manufacturing jobs in general accounted for 4.4% of growth, while R&D hiring saw a free fall of 25% and the once vaunted sales and marketing sector shrank 5%.

Europe was doing most of the overall hiring with an increase of 25%, while the job market in North America remained mostly unchanged and the Asia Pacific area, seen as a big growth market, actually reported a decline.

While quality management does not account for a ton of new jobs, there have been a number of very public announcements by companies like Hospira ($HSP) and Novartis ($NVS) about additions in quality control and manufacturing oversight.

- read the Pharmalot piece


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.